These discoveries leveraged the cutting-edge molecular biology techniques of the day to rapidly identify the genetic and biochemical basis of CF disease, tying defective chloride transport to impaired cellular function and providing a footing to understand the ways in which mutant CFTR might be therapeutically targeted. Here, CFTR is linked to cystic fibrosis.